Cardiovascular Mortality Gap Between the United States and Other High Life Expectancy Countries in 2000-2016.

ABSTRACT:

Objectives

Reductions in U.S. cardiovascular disease (CVD) mortality have stagnated. While other high life expectancy countries (HLCs) have also recently experienced a stall, the stagnation in CVD mortality in the United States appeared earlier and has been more pronounced. The reasons for the stall are unknown. We analyze cross-national variations in mortality trends to quantify the U.S. exceptionality and provide insight into its underlying causes.

Methods

Data are from the World Health Organization (2000-2016). We quantified differences in levels and trends of CVD mortality between the United States and 17 other HLCs. We decomposed differences to identify the individual contributions of major CVD subclassifications (ischemic heart disease [IHD], stroke, other heart diseas

SUBMITTER: Acosta E 

PROVIDER: S-EPMC9154236 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature